CHRU de Montpellier-Hopital St Eloi

Montpellier 34295

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Cancer, B-cell Lymphoma, Biliary Tract Cancer, Crohn's Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin, Metastatic Cancer, Multiple Myeloma, Ulcerative Colitis

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Study of Oral LOXO-338 in Patients With Advanced Blood Cancers — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed